- Lobbying
- Elizabeth AND Goss
Lobbying Arrangements Results for 'Elizabeth Goss'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Comprehensive Cancer Care Improvement Act, HR 1078/S 2790 |
American Society of Clinical Oncology
|
Turner & Goss LLP | |||
Details Development of omnibus legislation to address medical issues related to food allergies |
Food Allergy Research & Education
|
Turner & Goss LLP | |||
Details Comprehensive Cancer Survivorship Act, HR 9565 |
National Coalition for Cancer Survivorship
|
Turner & Goss LLP | |||
Details S. Res. 537, National Brain Tumor Awareness Month Resolution FY 2011 Defense Appropriations for pediatric brain tumor research |
North American Brain Tumor Coalition
|
Turner & Goss LLP | |||
Details PASTEUR Act of 2023 (S 1355 and HR 2940) |
Cystic Fibrosis Foundation
|
Turner & Goss LLP | |||
Details Cancer Survivorship legislation under development by Representative Wasserman Schultz Standards for distribution and use of monoclonal antibodies and antiviral treatments for the immune compromised |
Lymphoma Research Foundation
|
Turner & Goss LLP | |||
Details Drug shortage provisions of Food and Drug Administration Safety and Innovation Act Funding for blood cancer education program through the Labor, Health and Human Services, and Education appropriati... |
The Leukemia & Lymphoma Society
|
Turner & Goss LLP | |||
Details FY 2008 Appropriations for National Institutes of Health H.R. 154 - To Eliminate the Medicare Waiting Period |
North American Brain Tumor Coalition
Patient advocacy organization |
Turner & Goss LLP | |||
Details Endorsement of Dr. Monica Bertagnolli as National Institutes of Health Director |
Cancer Leadership Council
|
Turner & Goss LLP | |||
Details Provide input regarding Comprehensive Cancer Survivorship Act (HR 4364/S 2213) sponsored by Representative Wasserman Schultz in House of Representatives and Senator Klobuchar in Senate. Review drug... |
National Coalition for Cancer Survivorship
|
in-house lobbying | |||
Details COVID-19: vaccine and monoclonal antibody access for people with cancer |
LYMPHOMA RESEARCH FOUNDATION
|
in-house lobbying | |||
Details FY24 appropriations for the National Cancer Institute, specifically funding for programs related to the Childhood Cancer STAR Reauthorization Act and the Childhood Cancer Data Initiative (CCDI); FY... |
The Leukemia & Lymphoma Society
|
in-house lobbying | |||
Details H.R. 824: TELEHEALTH BENEFIT EXPANSION FOR WORKERS ACT OF 2023; ALL PROVISIONS H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTA... |
Cystic Fibrosis Foundation
|
in-house lobbying | |||
Details |
MERCK & CO, INC
|
ROPES & GRAY LLP |